Tech Company Financing Transactions
CalciMedica Funding Round
CalciMedica, operating out of La Jolla, raised $15 million from Valence Life Sciences, Bearing Capital Partners and Mesa Verde Venture Partners.
Transaction Overview
Company Name
Announced On
5/25/2020
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series C
Investors
Valence Life Sciences (Lead Investor) (Eric Roberts)
Proceeds Purpose
Proceeds from the financing will enable the Company to advance its lead drug candidate, Auxora, a potent and selective small molecule CRAC channel inhibitor that prevents CRAC channel overactivation, while also supporting general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 Coast Blvd S. 202
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel Leheny
Chief Financial Officer
Daniel Geffken
Chief Medical Officer
Sudarshan Hebbar
Chief Operating Officer
Michael Dunn
Chief Scientific Officer
Kenneth Stauderman
VP - General Counsel
John Dunn
Browse more venture capital transactions:
Prev: 5/25/2020: States Title venture capital transaction
Next: 5/25/2020: Magic Leap venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs